Mather Group’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Other funds holding DARE
FFA
BHWM
SS
CIAM
CSC
Mather Group's DARE Position: Q2 2026 in Review
Mather Group reduced its Dare Bioscience (DARE) stake by 1.2% in Q2 2026, selling an estimated $2 and leaving 84 shares worth $177. The position accounts for ﹤0.01% of the portfolio, ranked #1867.
Mather Group first reported a position in DARE in Q2 2024 and has held it in 7 quarters since. The position peaked at $490 in Q2 2024. 6 funds tracked by Wall St. Rank hold DARE as of Q2 2026.
- Mather Group held 84 shares of Dare Bioscience worth $177 as of Q2 2026.
- Mather Group sold 1 Dare Bioscience share in Q2 2026, an estimated $2.
- Dare Bioscience made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1867 holding.
- Mather Group first reported a position in Dare Bioscience in Q2 2024 and has held it in 7 quarters since.
- Mather Group's Dare Bioscience position peaked at $490 in Q2 2024.
- 6 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.
Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.